ational Prospective Hospital Cohort Study of Osteoporosis combined disease with 'zheng'
- Conditions
- osteoporosis
- Registration Number
- ITMCTR1900002833
- Lead Sponsor
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Aged >=40 years;
2. Gender: male or female;
3. Voluntarily participate in this research and sign the informed consent.
1. Suffering from diseases that affect bone metabolism, such as malignant tumors, diabetes, thyroid disease, parathyroid disease, adrenal disease, chronic liver and kidney disease;
2. Take antiepileptic drugs, letrozole, immunosuppressants and other drugs that affect bone metabolism.
3. Have undergone a total hysterectomy;
4. Have received regular anti-osteoporosis treatment.
Study & Design
- Study Type
- Epidemilogical research
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.